Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
6.93
-0.13 (-1.84%)
Oct 10, 2025, 2:45 PM EDT - Market open
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $299.69 million as of October 10, 2025. Its market cap has increased by 24.26% in one year.
Market Cap
299.69M
Enterprise Value
95.23M
1-Year Change
24.26%
Ranking
Category
Stock Price
$6.93
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $299.69M, a decrease of -66.63%. That is a compound annual growth rate of -48.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 305.31M | 89.09% |
| Dec 31, 2024 | 161.46M | -82.02% |
| Feb 8, 2024 | 898.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 760.65B |
| Johnson & Johnson | 454.24B |
| AbbVie | 406.87B |
| UnitedHealth Group | 334.65B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.01B |